Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $338 - $362
1 Added 1.61%
63 $21,000
Q2 2023

Aug 11, 2023

SELL
$314.42 - $351.91 $2,200 - $2,463
-7 Reduced 10.14%
62 $21,000
Q1 2023

May 15, 2023

SELL
$283.23 - $323.1 $450,618 - $514,052
-1,591 Reduced 95.84%
69 $21,000
Q4 2022

Feb 13, 2023

SELL
$285.76 - $321.48 $16,859 - $18,967
-59 Reduced 3.43%
1,660 $479,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $470,713 - $525,206
1,719 New
1,719 $498,000
Q1 2021

May 17, 2021

SELL
$207.02 - $241.31 $463,310 - $540,051
-2,238 Closed
0 $0
Q4 2020

Feb 17, 2021

SELL
$207.01 - $276.09 $731,573 - $975,702
-3,534 Reduced 61.23%
2,238 $528,000
Q3 2020

Nov 16, 2020

BUY
$255.65 - $303.1 $173,075 - $205,198
677 Added 13.29%
5,772 $1.57 Million
Q2 2020

Aug 12, 2020

SELL
$225.48 - $295.8 $74,633 - $97,909
-331 Reduced 6.1%
5,095 $1.48 Million
Q1 2020

May 14, 2020

SELL
$199.77 - $247.81 $119,062 - $147,694
-596 Reduced 9.9%
5,426 $1.29 Million
Q4 2019

Feb 14, 2020

SELL
$166.71 - $223.91 $282,240 - $379,079
-1,693 Reduced 21.94%
6,022 $1.32 Million
Q3 2019

Nov 15, 2019

BUY
$166.23 - $187.09 $89,597 - $100,841
539 Added 7.51%
7,715 $1.31 Million
Q2 2019

Aug 14, 2019

BUY
$164.61 - $190.37 $39,671 - $45,879
241 Added 3.48%
7,176 $1.32 Million
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $1.14 Million - $1.35 Million
6,935 New
6,935 $1.28 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.